Liudmila Hayeuskaya is a Sylmar, California based nurse practitioner. Active license number of Liudmila Hayeuskaya is 95014406 in California. Her current practice location is 14445 Olive View Dr, Sylmar. Patients can reach her at 747-210-4418. Liudmila Hayeuskaya is NP and her NPI number (Unique professional ID assigned by NPPES) is 1689195943. Liudmila Hayeuskaya has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Liudmila Hayeuskaya speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1689195943
NPI Enumeration Date:
27 Jun, 2017
NPI Last Update On:
30 Jul, 2021
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Liudmila Hayeuskaya are as mentioned below.
License Number
Specialization
State
Status
95014406
California
Primary
836742
Registered Nurse
California
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Liudmila Hayeuskaya 14445 Olive View Dr, Sylmar, California
Zip:
91342-1437
Patients can reach Liudmila Hayeuskaya at 14445 Olive View Dr, Sylmar, California or can call to book an appointment on 747-210-4418.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 10 March, 2025.